» Articles » PMID: 27199510

Icariin Prevents Cartilage and Bone Degradation in Experimental Models of Arthritis

Overview
Publisher Wiley
Specialties Biochemistry
Pathology
Date 2016 May 21
PMID 27199510
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Icariin (ICA) is an active compound extracted from Epimedium brevicornum Maxim. Previous reports have shown that icariin has a clinically significant therapeutic effect on rheumatoid arthritis. However, little is known about the mechanism by which icariin inhibits cartilage and bone degradation.

Methods: New Zealand rabbits were immunized with antigen-induced arthritis (AIA) and treated with icariin. Joint tissues from rabbits were studied by histological analysis, transmission electron microscopy (TEM), and micro-CT. The expression levels of receptor activator of nuclear factor-B ligand (RANKL) and osteoprotegerin (OPG) in joint tissues were determined using immunohistochemistry and real-time PCR analysis.

Results: Histological analysis and TEM sections of cartilage in the ICA treated group showed a low level of chondrocyte destruction. Micro-CT analysis showed that the bone mineral density value and bone structural level in ICA treated rabbits were significantly higher compared with those in the AIA group. Immunohistochemistry and real-time PCR analysis showed that icariin treatment reduced RANKL expression and enhanced OPG expression levels, as compared to the AIA group.

Conclusion: These data indicate that ICA suppresses articular bone loss and prevents joint destruction. This study also determined that ICA regulated articular bone loss in part by regulating RANKL and OPG expression.

Citing Articles

Investigating the molecular mechanism of epimedium herb in treating rheumatoid arthritis through network pharmacology, molecular docking, and experimental validation.

Ding C, Liu Q, You X, Yuan J, Xia J, Tan Y Mol Divers. 2025; .

PMID: 39821498 DOI: 10.1007/s11030-024-11019-z.


Therapeutic Potential of Plant-Derived Compounds and Plant Extracts in Rheumatoid Arthritis-Comprehensive Review.

Kciuk M, Garg A, Rohilla M, Chaudhary R, Dhankhar S, Dhiman S Antioxidants (Basel). 2024; 13(7).

PMID: 39061843 PMC: 11274232. DOI: 10.3390/antiox13070775.


Intervertebral disc degeneration-Current therapeutic options and challenges.

Samanta A, Lufkin T, Kraus P Front Public Health. 2023; 11:1156749.

PMID: 37483952 PMC: 10359191. DOI: 10.3389/fpubh.2023.1156749.


Effect of icariin on the HO-induced proliferation of mouse airway smooth muscle cells through miR-138-5p regulating SIRT1/AMPK/PGC-1α axis.

Huang Y, Ou G, Ma S, Liu M, Deng W Int J Immunopathol Pharmacol. 2023; 37:3946320231151515.

PMID: 36772811 PMC: 9926010. DOI: 10.1177/03946320231151515.


: An ancient Chinese herbal medicine in the prevention and treatment of rheumatoid arthritis.

Zhang L, Yan Y, He J, Wang P, Chen X, Lan T Front Chem. 2022; 10:1023779.

PMID: 36465876 PMC: 9712800. DOI: 10.3389/fchem.2022.1023779.


References
1.
LaBranche T, Jesson M, Radi Z, Storer C, Guzova J, Bonar S . JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production. Arthritis Rheum. 2012; 64(11):3531-42. DOI: 10.1002/art.34649. View

2.
Li D, Yuan T, Xiao Y, Wang R, Fan Y, Zhang X . Icariin: a potential promoting compound for cartilage tissue engineering. Osteoarthritis Cartilage. 2012; 20(12):1647-56. DOI: 10.1016/j.joca.2012.08.009. View

3.
Schulze-Tanzil G, Mobasheri A, de Souza P, John T, Shakibaei M . Loss of chondrogenic potential in dedifferentiated chondrocytes correlates with deficient Shc-Erk interaction and apoptosis. Osteoarthritis Cartilage. 2004; 12(6):448-58. DOI: 10.1016/j.joca.2004.02.007. View

4.
Meednu N, Zhang H, Owen T, Sun W, Wang V, Cistrone C . Production of RANKL by Memory B Cells: A Link Between B Cells and Bone Erosion in Rheumatoid Arthritis. Arthritis Rheumatol. 2015; 68(4):805-16. PMC: 4956406. DOI: 10.1002/art.39489. View

5.
Hoshiba T, Yamada T, Lu H, Kawazoe N, Chen G . Maintenance of cartilaginous gene expression on extracellular matrix derived from serially passaged chondrocytes during in vitro chondrocyte expansion. J Biomed Mater Res A. 2012; 100(3):694-702. DOI: 10.1002/jbm.a.34003. View